| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
834 |
735 |
$69K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,128 |
1,031 |
$61K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
276 |
252 |
$23K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
437 |
409 |
$23K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
324 |
249 |
$16K |
| 99000 |
|
599 |
581 |
$14K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
159 |
136 |
$11K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
250 |
218 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
191 |
185 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
244 |
207 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
319 |
296 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
58 |
54 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
92 |
69 |
$1K |
| 87428 |
|
14 |
14 |
$826.67 |
| 81002 |
|
236 |
187 |
$611.00 |
| 81025 |
|
18 |
13 |
$108.54 |